Significantly, the STN stimulation was able to increase the co-localization of TOMM20 (mitochondria marker) and LC3 in the TH+ cells in the SN of the PD model, nevertheless, this could be interrupted by treating with the mTOR activator (Supplementary Fig. 1a, b) (n = 6). This evidence concerns the gene MAP1LC3A and Parkinson disease.